Explore more publications!

Latin America News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Network.

Press releases published on January 5, 2026

Kohler Leads 2026 America’s Most Trusted® Studies for Toilets and Shower Door Surrounds
MedicareVideoGuide.com Reports Significant Medigap Rate Increases and Expands Support Services for Seniors
Sanford Housing Authority CEO Launches Economic Hubs for Jobs Plus Grant, Self-Sufficiency & Resident Services Programs
Encore Oilfield Services, LLC Announces Acquisition of Custom Compression Systems
Lloydshare Loyalty Participated in LASOS 2025 Summit in Punta Cana
Neuro Force One Welcomes Danny Hester as Brand Ambassador to Drive Innovation in Training and Recovery
C&M invertirá fuertemente en México en 2026 con soluciones integradas de comunicación e IA
Sobel Network Shipping and Charles A. Redden Announce Strategic Merger
Houston's Baker energy consultancy announces a workshop by its artist-in-residence Mary Baker
Hilliard Law Announces Promotion of Alex Hilliard and Bonnie J. Rickert to Partner
WebDaddy Pro Introduces Fair Pricing Charter to Ensure Stable Hosting Rates for Businesses
Helvetic Clinics Conforte son Statut de Leader Européen du Tourisme Dentaire avec une Croissance de 16% en 2025
Free LearningMole Platform Launches Over 500 Free Spanish-Language Educational Videos for Children
REEZ.io Expands Cryptocurrency Payment Options with Addition of 50+ Crypto Assets
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
ALPHAMIN ANNOUNCES RESIGNATION OF DIRECTOR
Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary
Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions